Molecular Microbiology (2009) 73(5), 826â€“843 äŠ?                                               doi:10.1111/j.1365-2958.2009.06764.x
                                                                                              published online 30 June 2009


 ethanolamine branch Kennedy pathway essential bloodstream form Trypanosoma brucei                                                                mmi_6764 826..843




Federica Gibellini,1 William N. Hunter1                        Introducton
Terry K. Smith2*
1
 Division Biological Chemistry Drug Discovery,              unicellular eukaryote Trypanosoma brucei School Life Sciences, University Dundee, Dundee              cause sleeping sickness humans Nagana DD1 5EH, Scotland, UK.                                             livestock, Sub-Saharan Africa. Current treatment
2
 Centre Biomolecular Sciences, North Haugh,                limitations efforts directed University, St Andrews KY16 9ST, Scotland, UK.                 assessment drug targets development new
                                                                   drugs. Studies T. brucei metabolism unravel
                                                                   novel unique aspects parasiteâ€™s biology Summary                                                            intrinsic directly appli-
                                                                   cable understanding disease assist Phosphatidylethanolamine (GPEtn), major phospho-
                                                                   development new therapies (van Hellemond lipid component trypanosome membranes, syn-
                                                                   Tielens, 2006).
thesized novo ethanolamine                                                                       area potential drug target novo
Kennedy pathway. composition GPEtn
                                                                   biosynthesis phospholipids (Ancelin Vial, 1986;
molecular species bloodstream form Trypa-
                                                                   HernÃ¡ndez-Alcoceba et al., 1997; Urbina, 2006; Choubey
nosoma brucei determined, new insights
                                                                   et al., 2007; Jez, 2007). Phospholipids contribute phospholipid metabolism, vitro vivo
                                                                   important structural role membrane prop-
characterization key enzyme Kennedy
                                                                   erties determine membrane fluidity cell surface
pathway, cytosolic ethanolamine-phosphate cyti-
                                                                   charge. implicated wide variety cellular
dylyltransferase (TbECT) . Gene knockout indicates
                                                                   processes, including cell division cell signalling TbECT essential growth survival,                                                                    (Dowhan, 1997). Ethanolamine derived phospholipids
highlighting importance Kennedy pathway
                                                                   (GPEtn, phosphatidylethanolamine), include dia- pathogenic stage African trypanosome.
                                                                   cylGPEtn, alkyl-acylGPEtn alkenyl-acylGPEtn (plas-
Phosphatiylserine decarboxylation, potential
                                                                   malogen), increase tendency membranes salvage pathway, does appear active cul-
                                                                   form non-bilayer structures, influencing membrane
tured bloodstream form T. brucei, upregu-
                                                                   fusion trafficking (Dowhan, 1997; Bakovic et al.,
lated Kennedy pathway disrupted.                                                                    2007). lipids affect folding, stabilization vivo metabolic labelling phospholipid composi-
                                                                   activity integral membrane-bound proteins tion analysis ESI-MS/MS knockout cells 
                                                                   certain cases GPEtn GPEtn-derived ethanolamine-
firmed significant decrease GPEtn species,                                                                    phosphoglycerol attached protein residues changes relative abundance phos-
                                                                   post-translational modification (Signorell et al., 2008a).
pholipid species. Reduction GPEtn levels                                                                    GPEtn donor ethanolamine-phosphate
profound influence morphology mutants
                                                                   capping glycosylphosphatidylinositol (GPI) anchor compromised mitochondrial structure                                                                    required attachment proteins outer
function, glycosylphosphatidylinositol
                                                                   leaflet cell membrane (Menon Stevens, 1992;
anchor biosynthesis. TbECT genetically
                                                                   Menon et al., 1993; Imhof et al., 2000). particularly
validated potential drug target African
                                                                   important bloodstream form T. brucei, trypanosome.
                                                                   relies dense coat GPI-anchored variant surface
                                                                   glycoprotein (VSG) circumvent attack host
                                                                   immune (Nagamune et al., 2000). Disruption Accepted 1 June, 2009.  correspondence. E-mail tks1@st-        GPEtn biosynthetic pathways T. brucei likely andrews.ac.uk; Tel. (+44) 1334 463412; Fax (+44) 1334 462595.      severely impair parasite homeostasis  use article permitted accordance Terms Conditions set http://www3.interscience.wiley.com/      constituent enzymes represent novel targets authorresources/onlineopen.html                                    chemotherapy.
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing                                                                                               Ethanolamine metabolism Trypanosoma brucei 827

   major pathways biosynthesis GPEtn             Results discussion CDP-ethanolamine (CDP-Etn) pathway, called Kennedy pathway, phosphatidylserine              Contributions Kennedy pathway GPSer
(GPSer) decarboxylation pathway. CDP-Etn pathway                decarboxylation pathway GPEtn biosynthesis consists enzymatic steps. Initially, ethanolamine          bloodstream form T. brucei
kinase (EK, EC 2.7.1.82) catalyses ATP-depen-                   relative contribution GPSer decarboxylation
dent phosphorylation ethanolamine (Etn), forming                 pathway GPEtn biosynthesis assessed stable
ethanolamine-phosphate (Etn-P), product                  isotope labelling d3-serine normal culturing media
ADP. stage  CTP:ethanolamine-phosphate cyti-             overnight, order allow adequate time phospholipid
dylyltransferase (ECT, EC 2.7.7.14), subject            synthesis dynamic equilibrium phospho-
study, utilizes Etn-P CTP form high-energy               lipids pools reached. Subsequent analysis donor CDP-Etn release pyrophosphate.                    phospholipid molecular species electrospray ionization reaction considered rate-limiting                 tandem mass spectrometry (ESI-MS/MS) allowed step Kennedy pathway (Sundler Akesson,                   overall contribution GPSer decarboxylation
1975). Diacylglycerol: CDP-ethanolamine ethanolamine-               pathway GPEtn biosynthesis assessed. phosphotransferase (EPT, EC 2.7.8.1) catalyses final            labelling d3-serine readily incorporated newly
reaction pathway, utilizing CDP-Etn diacylglyc-          synthesized d3-GPSer, virtually super imposable
erol alkyl-acylglycerol form diacylGPEtn plasmalo-         pre-existing unlabelled GPSer visualized gen, respectively, CMP product.                          neutral loss scans m 89 87 respectively (compare
   alternative route synthesis GPEtn           Fig. 1A B).
decarboxylation GPSer phosphatidylserine                       Similarly, newly synthesized d3-GPEtn formed decarboxylase (PSD). pathway actually sole              GPSer decarboxylation newly synthesized d3-GPSer
route GPEtn biosynthesis Escherichia coli            detected parent ion scan analysis lipids major Saccharomyces cerevisiae,                  produce collison induced 199 m fragment nega-
yeast Kennedy pathway active (Dowhan,                   tive ion mode, opposed bulk GPEtn visualized
1997). mammalian cells relative contributions             collision induced 196 m fragment ion (compare pathways GPEtn formation cell-type depen-               Fig. 1C D). Table S1 shows annotation dent, GPSer decarboxylation prevailing BHK21                GPEtn molecular species identified bloodstream form CHO cells Kennedy pathway prevailing                 T. brucei. mammalian tissues (hamster heart, rat heart,                      previous work (Rifkin et al., 1995) kidney liver), cultured glioma cells (Vance,                indicate bloodstream form T. brucei able syn-
2008).                                                              thesize GPEtn GPSer decarboxylation,    Metabolic labelling pulse-chase experiments pro-             experiment clearly shows trace amounts d3-GPEtn
vided evidence T. brucei GPEtn                (Fig. 1D), differ significantly novo syn- ethanolamine serine,            thesized GPEtn Kennedy pathway (Fig. 1C). Kennedy pathway used GPEtn biosyn-               suggests GPSer decarboxylation contributes little thesis (Rifkin et al., 1995). recently confirmed        biosynthesis GPEtn conditions RNA interference insect form parasite (Signo-         confirms importance Kennedy pathway rell et al., 2008a,b),  detailed studies      biosynthesis GPEtn bloodstream T. brucei.
performed bloodstream T. brucei.  time, putative T. brucei CTP:ethanolamine-
                                                                    Identification, cloning sequencing TbECT
phosphate cytidylyltransferase (TbECT ) gene (Tb11.
01.5730) encodes functional enzyme, charac-                genome sequence T. brucei (Berriman et al., 2005)
terize enzyme activity substrate requirements.              invaluable resource understanding Formation bloodstream form T. brucei TbECT condi-              molecular cellular biology important parasite. tional double knockout (cKO) allowed demonstrate              putative TbECT (Tb11.01.5730) identified TbECT essential non-permissive condi-             T. brucei genome database (http://www.genedb.org); tions synthesis GPEtn GPI-anchors severely            putative open reading frame (ORF) PCR-amplified
compromised. GPSer decarboxylation                genomic DNA (Lister 427), cloned sequence
makes minor contribution bulk GPEtn biosynthe-            submitted GenBank Nucleotide Sequence Database
sis compensate loss Kennedy            Accession number FM992871. complete ORF
pathway TbECT cKO. findings suggest              encodes protein 384 residues calculated therapeutic opportunities targeting Kennedy           molecular mass 43.4 kDa. TbECT shows 
pathway.                                                            siderable similarity ECTs mammalian organisms

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 828 F. Gibellini, W. N. Hunter T. K. Smith äŠ?




Fig. 1. ESI-MS/MS spectra following molecular species: GPSer  ; (d3)-GPSer (B); GPEtn (C) (d3)-GPEtn (D) bloodstream
T. brucei labelled (d3)-serine overnight. Data normalized largest peak display vertical axes linked order directly
compare intensities non-deuterated versus deuterated phospholipid species.



 shares 40  sequence identity human ECT,                      expression vector pET20bTEV. vector encodes
unsurprisingly closely related putative ECTs                   hexa-histidine tag C-terminal protein, kinetoplastids Leishmania major                           removed proteolytic cleavage T. cruzi, 59  62  sequence identity respectively                   Tobacco Etch Virus (TEV) protease (Fig. S1A). (Fig. 2A B). Like previously characterized ECTs,                        protein expressed purified described TbECT contains large tandem repeated sequences,                         Experimental procedures. Typical yields 20â€“25 mg
probably result gene duplication (Nakashima et al.,                    litre culture. TbECT stored -80Â°C 1997; Bladergroen et al., 1999). N-terminal repeat                   buffer containing 5  glycerol loss activity strongly conserved ECTs members                        period months. cytidylyltransferase family: glycerol-3-phosphate cyti-                    Matrix-assisted laser desorption/ionization (MALDI)
dylyltransferases (GCT) N-terminal domain                        mass spectrum cleaved recombinant TbECT
choline-phosphate cytidylyltransferases (CCT).                              returned molecular mass 44 623 Da (theoretical
   signature motifs characterize cytidylyl-                value predicted recombinant TbECT: 44 622 Da).
transferase family present TbECT sequence:                          Analytical ultracentrifugation performed conserved GX(Y/F)DXXHXGH sequences, contain-                            untagged TbECT. sample displayed single species
ing HXGH motive (47HFGH 227HAGH, Fig. 2A,                           mass ~52 kDa, agrees theoretical mass
boxed) adjacent Asp44 Asp224 (Fig. 2A,                         monomer (Fig. S1B).
asterisks); RTX(G/C/S)ISTT motif (152RTECISTT)                             Interestingly, rat human ECTs, (Fig. 2A, underlined); regions 96KWVDAVI                        TbECT shares high sequence identity, form dimers 278RYVDDVV (Fig. 2A, double underlined). struc-                     higher aggregates solution (Sundler, 1975; Tie ture Bacillus subtilis GCT (Weber et al., 1999; Pattridge                Bakovic, 2007). reported monomeric ECT
et al., 2003) revealed HXGH motif                          S. cerevisiae (Ohtsuka et al., 2006), shares
RTX(G/C/S)ISTT motif involved formation                   34  sequence identity TbECT (Fig. 2), despite CTP binding site, motif involved                homologues having sequence motif predicted
formation dimer interface.                                             play role dimer interface.
                                                                               TbECT catalysed formation CDP-ethanolamine
                                                                            ethanolamine-phosphate, CTP magnesium-
Recombinant expression characterization TbECT
                                                                            dependent manner (Fig. S2). pH optimum 7.5 establish TbECT active ethanolamine-                            (Fig. 3A) TbECT displays Km 12.09 â«¾ 0.87 mM
phosphate cytidylyltransferase obtain material                   (Fig. 3B) ethanolamine-phosphate Km characterization properties, TbECT cloned                    12.67 â«¾ 0.78 mM (Fig. 3C) CTP. values

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                                        Ethanolamine metabolism Trypanosoma brucei 829




Fig. 2.  ClustalW alignment predicted amino acid sequences Trypanosoma brucei ECT (Q382C3-1) ethanolamine
cytidylyltransferases glycerol-3-phosphate cytidylyltransferases eukaryotes: Leishmania major (Q4Q5J3), Trypanosoma cruzi
(Q922E4), Homo sapiens (Q99447), Saccharomyces cerevisiae (P33412) ECTs Bacillus subtilis GCT. Residues shaded according percentage identity using software Jalview 2.08.1. Boxed underlined regions characterisitic signature motif cytidylyltransferases.
B. Phylogenetic analysis ECTs GCTs Fig. 2A plus ECTs Mus musculus (Q922E4), Rattus norvegicus (O88637),
Chlamydomonas reinhardtii (Q84JV7) Arabidopsis thaliana (Q9ZVI9).




compare favourably Km values previously charac-                     enzyme,  able utilize dCTP, terized ECTs rat (KmCTP = 53 mM; KmETN-P = 65 mM                       reduced rate, implying enzyme able (Sundler, 1975) order magnitude                        discriminate deoxyribonucleotide ribo-
lower corresponding Kms mouse (Tie                          nucleotide moiety. consistent trace amounts Bakovic, 2007). Particularly striking unusually                      dCDP-ethanolamine bloodstream form
low Km cofactor CTP; reflect relatively                T. brucei (Rifkin et al., 1995).
low intracellular concentration nucleotide triphos-                    Interestingly, TbECT unable accept 2-aminoethyl
phate T. brucei (Hofer et al., 1998) compared                       phosphonate (AEP) substrate. AEP essential pool present mammalian cells (Stryer, 1995;                          metabolite formation phosphonolipids, Lazarowski Boucher, 2001) Vmax TbECT                          carry covalent bond phosphorous 1.55 â«¾ 0.03 mmol min-1 mg-1, corresponding kcat                     carbon nitrogenous base (Baer Stanacev,
1.15 s-1.                                                                   1964).  previous studies (Ferguson et al., 1982)
  TbECT activity selective CTP,                   failed detect phosphonolipids T. brucei, unlike activity detected ATP, GTP UTP (Table S2).                   closely related trypanosomatid, T.cruzi, 
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 830 F. Gibellini, W. N. Hunter T. K. Smith äŠ?

                                                                            reflected absence enzymes biosyn-
                                                                            thesis AEP T. brucei (Sarkar et al., 2003)                                                                              shown  substrate specificity TbECT.


                                                                            Construction TbECT conditional null mutant

                                                                            assess importance TbECT                                                                             entire Kennedy pathway survival bloodstream
                                                                            form T. brucei, conditional null knockout generated
                                                                            characterized.
                                                                               Preliminary analysis showed TbECT gene                                                                             present single copy haploid genome                                                                             expressed bloodstream form insect life cycle
                                                                            stages (Fig. S3). conventional mutagenesis approach
                                                                            (Martin Smith, 2006a) followed: allele                                                                             replaced puromycin resistance gene (PAC) gener-
                                                                            ating DECT::PAC cell line; haemagglutinin (HA)-
                                                                            tagged tetracycline-inducible ectopic copy gene                                                                             introduced ribosomal DNA, yielding cell line
                                                                            ECT-HA Ti DECT::PAC; maintaining expression                                                                             ectopic copy addition tetracycline, remaining
                                                                            allele replaced hygromycin resistance gene
                                                                            resulting conditional double knockout cell line ECT-
                                                                            HA Ti DECT::PAC/DECT::HYG. genotype condi-
                                                                            tional null mutant verified Southern blot analysis,
                                                                            ectopic copy present (Fig. 4A, lane 3).


                                                                            TbECT essential T. brucei bloodstream form
                                                                            establish ECT essential gene, cell
                                                                            line ECT-HA Ti DECT::PAC/DECT::HYG cultured                                                                             presence absence tetracycline growth rates
                                                                            compared wild-type. Triplicate cultures cell
                                                                            type inoculated 1 Â¥ 105 cells ml-1 subcultured
                                                                            days necessary. presence tetra-
                                                                            cycline,  permissive conditions allow expres-
                                                                            sion ECT-HA Ti, cells showed normal growth kinetics,
                                                                            comparable wild-type cells (Fig. 4B).                                                                              cultured tetracycline-free media (non-permissive condi-
                                                                            tions), cells immediately displayed reduced growth rate
                                                                            48 h attained approximately half
                                                                            cell density wild-type (Fig. 4B). 72 h                                                                             increasing cell debris observed                                                                             day 4 cell numbers fell limit detection light
                                                                            microscopy. RT-PCR confirmed TbECT mRNA disappear-
Fig. 3. Analysis CDP-ethanolamine formation recombinant
TbECT.                                                                      ance 24 h non-permissive conditions (Fig. 4C).  Ethanolamine-phosphate cytidylyltransferase activity                  7â€“8 days tetracycline removal live cells
determined end-point assay function pH described                                                                             visible normal growth rates Experimental procedures.
B C. Determination TbECT Michaelis-Menten constants              resumed. resumption growth revertant
ethanolamine-phosphate CTP (inserts Lineweaverâ€“Burk                cells overcoming tetracycline control, demon-
plots). (B) CTP concentration held constant (0.1 mM)                                                                             strated reappearance TbECT mRNA ethanolamine-phosphate concentration varied. (C)
Ethanolamine-phosphate concentration held constant (0.1 mM)             cells (Fig. 4C). phenomenon, described times CTP concentration varied.                                         T. brucei conditional null mutants essential
                                                                            genes (Martin Smith, 2006a), ascribed 
                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                             Ethanolamine metabolism Trypanosoma brucei 831

                                                                                       Fig. 4. TbECT essential survival                                                                                        bloodstream form Trypanosoma brucei                                                                                        culture.
                                                                                        Confirmation genotype T. brucei ECT
                                                                                       conditional double knockout cell line.
                                                                                       Southern-blot analysis NcoI-digested
                                                                                       genomic DNA (5 mg); ECT ORF probe
                                                                                       shows allelic TbECT 4.4 kb ectopic
                                                                                       copy TbECT-HATi ~5 kb 1; parental cells
                                                                                       (SM) 2; DECT::PAC/ECT-HA Ti 3;
                                                                                       DECT::PAC/DECT::HYG/ECT-HA Ti 4;
                                                                                       Undigested DNA.
                                                                                       B. Growth curves T. brucei parental cells (1
                                                                                       â€“ filled circles) TbECT conditional
                                                                                       knockout cells grown presence (2 â€“
                                                                                       circles) absence (3 â€“ filled triangles)
                                                                                       tetracycline.
                                                                                       C. RT-PCR amplification TbECT RNA
                                                                                       transcripts total RNA extracted                                                                                        TbECT conditional null mutants grown                                                                                        absence tetracycline 0, 12, 24, 36                                                                                        48 h. upper panel shows RT-PCR
                                                                                       products using primers specific TbECT;
                                                                                       middle panel shows PCR-negative
                                                                                       control, reverse transcriptase;                                                                                        lower panel shows loading control using
                                                                                       tubulin tyrosine-ligase (TbTTL) primers.




deletion tetracycline repressor protein gene (Roper          overall cellular dimensions  â€˜stumpy-likeâ€™) et al., 2002).                                                      compared control cells (Fig. S4A, compare panels 1
                                                                    2 3 4). Determination average cell
                                                                    volume (CASY cell counter, SEDNA Scientific) confirmed
TbECT deprivation affects cellular dimensions                                                                     average reduction 30  cell volume subcellular architecture
                                                                    48 h growth tetracycline free media (Fig. S4B).
Scanning electron micrographs TbECT cKO cells                      Transmission electron microscopy used investi-
deprived tetracycline 36 h suggested reduction          gate subcellular architecture TbECT cKO cells 
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 832 F. Gibellini, W. N. Hunter T. K. Smith äŠ?

various time points tetracycline removal. shown                 lane 3); downregulation Fig. 5A (panels bâ€“e) main morphological defect                          EK1 channelling excess Etn-P appears abnormally enlarged mitochondria,                          catabolic metabolic pathways. means usually narrow tubular structure                 phenotypical effects ECT knockout SM parental cells (Fig. 5A, panel . abnormal                         disappearance CDP-Etn downstream metabo-
enlargement mitochondria quantified 60                   lites, e. GPEtn, accumulation suitable transmission electron micrographs relevant                      toxic levels Etn-P.
time points. 36 h tetracycline ~70                           GPEtn donor terminal phospho-
examined mitochondria significantly enlarged,                    ethanolamine group GPI anchors (Menon et al., 1993;
increased ~90  42 h (Fig. 5A, panel f).                               Imhof et al., 2000), biosynthesis previ-
   investigate enlargement reflects loss                  ously validated drug target African trypano- function organelle, trypanosomes stained                      tested possibility reduction cellular membrane potential-dependent fluorescent dye                       GPEtn produce knock effect GPI
Mitotracker Red (Fig. 5B) observed fluorescence                      pathway.
microscopy. TbECT cKO trypanosomes grown non-                            [3H]Man labelling parental cells TbECT
permissive conditions 36 h accumulation                   cKO cells grown permissive conditions highlighted dye mitochondria, volume                   formation expected mature GPI anchor glycolipids organelle appears increased (Fig. 5B, lane c),                    C (Fig. 6A, lanes 7 8) previously reported
suggesting enlarged, mitochondria                 (Martin Smith, 2006b).  conditional
able maintain membrane electrostatic potential.                      double knockout cells grown non-permissive conditions  42 h tetracycline removal, dye                      36 h displayed marked decrease signal completely disappears, suggesting loss                     labelled species (Fig. 6A, lane 9), meaning function (Fig. 5B, lane d). Changes mitochondrial mor-                   decrease GPEtn synthesis, deletion TbECT,
phology function observed mam-                      detrimental effect biosynthesis mature GPI
malian PSD mutants (Steenbergen et al., 2005)                        anchors.
T. brucei procyclic ACP mutants result decrease                      addition, [3H]Myr labelling shows GPEtn organelle (Guler et al., 2008).                            slight decrease phospholipids synthe-
                                                                            sized conditional double null cells grown non-
                                                                            permissive conditions 36 h (Fig. 6A, compare lanes
Phenotype analysis TbECT conditional null mutants
                                                                            10â€“12). vivo labelling
                                                                               confirm cells viable time biochemical phenotype conditional double                         labelling, ability cells perform normal rates knockout cells investigated vivo labelling                   protein synthesis confirmed. wild-type cells [3H]Etn, [3H]Ser, [3H]Man [3H]Myr (Fig. 6)                     conditional double null cells grown presence ascertain effect TbECT disappearance GPEtn                        absence tetracycline 36 h showed similar amounts
biosynthesis potential knock effects GPI anchor                   [35S]methionine incorporation newly synthesized
biosynthesis general phospholipid metabolism.                       proteins (Fig. 6B), meaning biochemical changes
results clear decrease GPEtn formed                       detected vivo labelling experiments  Kennedy pathway cKO non-permissive                         sequence TbECT deprivation general
conditions (Fig. 6A, compare lanes 1â€“3). GPEtn                         loss viability. note 48 h, protein synthesis decrease does prompt upregulation GPSer                       partially compromised (data shown), 36 h
decarboxylation pathway, GPEtn observed                         chosen biochemical phenotyping. newly synthesized GPSer (Fig. 6A, lanes 4â€“6). represents fundamental difference behav-
                                                                            Lipid profile TbECT conditional null mutants iour mammalian cells culture: Kennedy pathway
                                                                            ESI-MS/MS favoured pathway biosynthesis GPEtn ethanolamine readily available culture                       ascertain decrease GPEtn decrease
media, GPSer decarboxylation pathway com-                       particular GPEtn species global decrease pensate conditions ethanolamine deprivation                        GPEtn species, affected composition
(Voelker, 1984).                                                            phospholipid classes, cell extracts    expected, blocking Kennedy pathway ECT                     TbECT cKO cell line grown presence absence level results disappearance CDP-Etn product                   tetracycline 36 h semi-quantitatively analysed (Fig. 6C, lane 3). Surprisingly  does trans-                ESI-MS/MS compared wild-type (Figs 7 8
late accumulation substrate Etn-P (Fig. 6C,                  Figs S5â€“8). negative positive ion survey

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                                       Ethanolamine metabolism Trypanosoma brucei 833

              



              B




Fig. 5. Loss ECT activity affects mitochondrial morphology function.  Transmission electron micrographs TbECT cKO cells taken   36 (b) 42 h (câ€“e) tetracycline removal media. (f) Quantification sections displaying abnormal enlargement mitochondria wild-type TbECT cKO cells different
time points tetracycline removal (SM parental cell, n = 43; TbECT cKO + Tet, n = 83; TbECT cKO + Tet, n = 65; TbECT cKO -Tet42 h,
n = 68). Scale bar = 2 mm.
B. Mitotracker red CMXRos used stain live cells prior fixation (3); cells counterstained DAPI (2); corresponding
phase contrast images shown (1), merged fluorescence-phase images shown (4). Mitotracker fluorescence images collected acquisition time 542 ms allow data examined differences fluorescence intensity.  , SM parental
cells; (b) TbECT cKO cells grown presence tetracycline; TbECT cKO cells grown absence tetracycline 36 h (c) 42 h (d).


Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 834 F. Gibellini, W. N. Hunter T. K. Smith äŠ?




Fig. 6. Phenotype analysis TbECT conditional knockout vivo labelling.  SM parental cells (lanes 1, 4, 7 10); TbECT cKO cells grown presence (lanes 2, 5, 8 11) absence tetracycline 36 h
(lanes 3, 6, 9 12) labelled [3H]ethanolamine ([3H]Etn, lanes 1â€“3), [3H]serine ([3H]Ser, lanes 4â€“6), [3H]mannose ([3H]Man,
lanes 7â€“9) [3H]myristate ([3H]Myr, 10â€“12), lipids extracted, desalted run HPTLC described Experimental procedures.
Incorporation radiolabel lipids detected fluorography. Lipid standards GPEtn, lysoGPEtn GPSer indicated left.
Glycolipids C indicated right.
B. Cells labelled [35S]methionine proteins extracted separated 4â€“10  SDS-PAGE gel. Proteins detected Coomassie Blue staining (lanes 1â€“3) fluorography (lanes 4â€“6). Lanes 1 4, SM parental cells; lanes 2 5, TbECT cKO cells
grown presence tetracycline; lanes 3 6, TbECT cKO cells grown absence tetracycline 36 h.
C. water-soluble metabolites Kennedy pathway extracted cells labelled [3H]Etn run HPTLC. metabolites
Etn, Etn-P CDP-Etn indicated right.


scans TbECT cKO grown non-permissive                           GPEtn investigated. Figure 7 shows major
conditions contain substantial differences control                 GPEtn peak encompassing molecular species mass
ones, highlighted asterisks (Fig. S5A B).                     range m 724â€“732 (e-36:3 â€“ 36:0, Table S1) 
   detailed investigation individual phospho-                 siderably reduced TbECT cKO grown absence
lipid classes conducted parent ion neutral loss                  tetracycline 36 h, compared parental
scanning specific collision induced fragment ions char-                  cells TbECT cKO grown presence tetracy-
acteristic phospholipids class. Initially effect            cline (Fig. 7, compare B C). principal

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                               Ethanolamine metabolism Trypanosoma brucei 835




Fig. 7. GPEtn phospholipid analysis ESI-MS/MS. Ethanolamine-containing phospholipids analysed ESI-MS/MS negative ion
mode using parent-ion scanning collision induced fragment m 196. arrows indicate peaks internal standard GPEtn
(15:0/15:0), subjected ninefold magnification clarity.  SM parental cells.
B. TbECT cKO cells grown presence tetracycline.
C. TbECT cKO cells grown absence tetracycline 36 h.
D. Daughter ion spectrum m 726 [M-H]- ion.



component peak identified plasmalogen                 18:2) (Fig. 8D). phenomenon attributed GPEtn (e-18:0/18:2) daughter ion scanning m 726              alkyl-acyl-glycerol utilized EPT (Fig. 7D). relative ratio intensity GPEtn          step Kennedy pathway lack CDP-Etn, (e-18:0/18:2) peak m 726 internal              excess lipid/substrate channelled standard GPEtn (15:0/15:0), used compare                  formation ether GPCho phospholipids GPEtn different samples showed             CDP-choline branch Kennedy pathway. plasmalogen GPEtn 36 h ECT               GPEtn  18:0/18:2) species normally proceed
deprivation reduced            formation plasmalogen form GPEtn (e-18:0/
contained parental cells TbECT cKO grown              18:2), GPCho  18:0/18:2) remains alkyl-acyl presence tetracycline.                                     form.
   Parallel GPEtn reduction correspond-              addition, cKO cells grown absence ing increase phosphatidylcholine (GPCho) peak              tetracycline 36 h increase phospha-
m 768â€“776 includes phospholipids carry               tidic acid (GPA) phosphatidylglycerol (GPGro) peaks kind fatty acyl constituents (e-36:3 â€“ 36:0)               m 749 773 respectively (Fig. S6), assessed (Fig. 8, compare B C), major species             parent ion scanning negative ion mode glycerol-
identified daughter ion scanning GPCho  18:0/                cyclic phosphate collision induced ion m 153. 
Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 836 F. Gibellini, W. N. Hunter T. K. Smith äŠ?




Fig. 8. GPCho sphingomylein phospholipid analysis ESI-MS/MS.
Aâ€“C. Choline-containing phospholipids analysed ESI-MS/MS positive ion mode using parent-ion scanning collision induced
fragment phosphoryl-choline m 184. arrows indicate peaks internal standard GPCho (21:0/21:0).   SM parental cells; (B)
TbECT cKO cells grown presence tetracycline; (C) TbECT cKO cells grown absence tetracycline 36 h.
D. Daughter ion spectrum m 773 [M + H]+ ion.



peaks identified GPA (18:0/22:5) GPGro                          stream form T. brucei GPSer synthesized base-
(18:0/18:2) daughter ion ES/MS-MS (Fig. S6D E).                      exchange reaction GPEtn, pathway increase GPGro (18:0/18:2, m 773) mir-                    present procyclic form parasite (Signorell
rored cKO cells grown presence tetracy-                    et al., 2008b).
cline, hypothesize increase phospholipid species result trypanosome
                                                                            ECT depletion knock effect GPI anchor
metabolism attempting compensate suboptimal
                                                                            biosynthetic pathway GPEtn overall unused lipid accep-
tor GPEtn EPT.                                                      effect GPEtn deprivation GPI-anchor bio-
   Interestingly, total composition profile               synthetic pathway studied using GPSer phosphatidylinositol (GPIno)                         trypanosomal cell-free  vitro assay altered significantly cKO absence tetracy-                 throughput GPI pathway maximized
cline (Figs S7 S8 respectively). correlates                   (Smith et al., 1996). Washed membranes incubated observation GPSer biosynthesis margin-                     GDP-[3H]Man UDP-GlcNAc presence ally affected reduction GPEtn levels (Fig. 6, lanes                 dithiothreitol (DTT) (Fig. 9, lane 2), leading forma-
4â€“6) exclude possibility blood-                    tion dolichol-phosphate-[3H]mannose (DPM) 
                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                               Ethanolamine metabolism Trypanosoma brucei 837

                                                                      ary antibody  expected, cytosolic localization
                                                                      observed (Fig. 10A). confirmed Western
                                                                      blot analysis subcellular fractions probed                                                                       anti-HA antibody (Fig. 10B).
                                                                        Cytosolic localization ECT T. brucei shared                                                                       mammalian cells (Vermeulen et al., 1993; Bleijerveld et al.,
                                                                      2004);  differs considerably localization
                                                                      enzyme plants algae, studies                                                                       Ricinus communis endosperm, Arabidopsis thaliana                                                                       Chlamydomonas reinhardtii reveal mitochondrial  peri-
                                                                      mitochondrial) ER localization (Mizoi et al., 2006;
                                                                      Wang Moore, 1991; Yang et al., 2004).


                                                                      Conclusions

                                                                      demonstrated Kennedy pathway                                                                       sole relevant route GPEtn biosynthesis Fig. 9. Effects GPEtn deprivation GPI intermediates             bloodstream form T. brucei required formation. T. brucei cell-free SM parental cells (lanes 1 2), TbECT cKO cells grown presence (lane 3)             survival.
absence tetracycline 36 (lane 4) 42 h (lane 5)           highlighted differences behaviour mam-
labelled GDP-[3H]mannose presence absence           malian cells culture alternative pathway,
phenylmethanesulphonyl fluoride, indicated.
                                                                      GPSer decarboxylation, compensate loss                                                                       Kennedy pathway deprivation precursor
[3H]mannosylated       GPI      intermediates,      including         ethanolamine culture media (Voelker, 1984); Man1GlcN-PI (M1), Man2GlcN-PI (M2), Man3GlcN-PI                       bloodstream T. brucei GPSer decarboxylation route
(M3), Man3GlcN-(acyl)-PI(aM3), EtN-P-Man3GlcN-PI (Aâ€²)                 appears insignificant biosynthesis GPEtn sn-2 lyso species Aâ€² (Q).                                  unable compensate loss Kennedy
   prolonged absence tetracycline, e. 42 h,             pathway disrupted TbECT gene
formation GPI intermediates downstream                  knockout.
Etn-P addition (glycolipid Aâ€² Q) greatly reduced,             work suggested intriguing difference paralleled increase GPI intermediate               phospholipid metabolism main life cycle stages
upstream reaction (aM3; Fig. 9, lane 4). dem-             African trypanosome. procyclic form GPSer onstrates GPEtn deprivation specific effect           generated base-exchange reaction GPEtn GPI pathway, causing arrest level Etn-P          downregulation Kennedy pathway completely
addition.                                                             blocked GPSer synthesis (Signorell et al., 2008a).
   positive control GPI pathway stalled               Kennedy pathway level Etn-P addition, cell-free pre-                disrupted bloodstream form T. brucei, GPSer
incubated phenylmethanesulphonyl fluoride (PMSF),                biosynthesis occurred levels comparable inhibits acylation GPI intermediates (Fig. 9,            wild-type.  life cycle stage GPSer biosyn-
lane 1), preventing addition Etn-P (Guther et al.,         thesis likely proceed coupling serine 1994).                                                                CDP-DAG represents major difference                                                                       phospholipid metabolism life cycle stages.
                                                                         lethality TbECT cKO non-permissive
TbECT localized cytosol
                                                                      conditions shows corresponding cytidylyl- optimal TbECT activity occurs neutral pH                     transferase involved choline branch Kennedy
(Fig. 4A) signal peptides identified             pathway unable compensate loss etha-
amino acid sequence, cytosolic localization                  nolamine branch. generation TbECT cKO cell
enzyme hypothesized. intracellular location               line allowed assessment phenotypic changes
assessed taking advantage HA tag present                 GPEtn deprivation. showed morphol- C-terminus ectopic copy cell line ECT-              ogy mutants mitochondrion affected
HA Ti DECT::PAC/DECT::HYG cultured presence                 early stage later mitochondrial function tetracycline. Detection achieved immunofluores-                disrupted. GPI anchor biosynthesis affected cence using primary antibody HA-tag               blocked level Etn-P addition, GPEtn
fluorescein 5â€²-isothiocyanate (FITC)-conjugated second-               donor substrate.

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 838 F. Gibellini, W. N. Hunter T. K. Smith äŠ?




Fig. 10. Subcellular localization ECT-HA bloodstream form T. brucei cells.  Cells expressing ECT-HA costained HA epitope nuclear marker DAPI. (1) Phase contrast image. (2) DAPI staining.
(3) HA epitope staining FITC detection. (4) Merged image.
B. Western blot analysis subcellular fractions cells expressing ECT-HA differential centrifugation. Lane 1, microsomal fraction; lane
2, large granular fraction; lane 3, cytosolic fraction.


   Overall, perturbation lipid homeo-                   GPEtn(15:0/15:0);      1,2-dimyristoyl-sn-glycero-3-[phospho-
stasis potential interfering numerous cel-                  rac-(1-glycerol)], GPGro(14:0/14:0); 1,2-diheneicosanoyl-sn-
lular processes structures, explains relative                 glycero-3-phosphocholine,        GPCho(21:0/21:0);       1,2-
                                                                            dimyristoyl-sn- glycerol-3-[phospho-L-serine], GPSer(14:0/
rapidity cell death makes TbECT attractive drug
                                                                            14:0); 1-dodecanoyl-2-tridecanoyl- sn-glycero-3-
target.                                                                     phospho-(1â€²-myo-inositol), GPIno(12:0/13:0) purchased
   Furthermore, characterization enzymatic                       Avanti Polar Lipids.
properties ECT provided invaluable information future experiments aimed developing inhibitors new therapeutic agents African trypanosome.                     Cloning sequencing T. brucei ECT

                                                                            putative TbECT gene amplified T. brucei strain
Experimental procedures                                                     427 genomic DNA 5â€² 3â€² untranslated
                                                                            regions (UTRs) 278 402 bp, respectively, using Pfu
Reagents                                                                    DNA polymerase forward reverse primers
                                                                            5â€² - ATAAGTAAgcggccgcGCTAAAGGTGTTGGTGAAACTAG
Chemicals purchased Sigma-Aldrich Fluka.                       CGC-3â€² (F1) 5â€²-ATAAGTAAgcggccgcTGGTGAAAC
Restriction endonucleases DNA modifying enzymes                         AAAACGTTAGTACA-3â€² (R2) containing NotI restric- New England Biolabs Promega. [2-3H] ethano-                    tion site (lower case). resulting 1.8 kb (ECT UTRs)
lamine (50 Ci mmol-1) D-[2-3H] mannose (15 Ci mmol-1)                   fragment cloned pCR-Blunt-II TOPO vector (Invitro- purchased Amersham. [9,10â€“3H(N)]- tetrade-                        gen) yielding pCR-Blunt-II-flECT construct. Clones canoic acid (myristic acid) (47 Ci mmol-1) Perkin                  sequenced compared annotated Gene Data
Elmer, L-[3â€“3H]-serine (20 Ci mmol-1) GDP-                        Bank sequences.
[3H]mannose (20 Ci mmol-1) ARC. L-[35S] methion-
ine (1175 Ci mmol-1) MP Biochemicals. L-[2,2,3â€“
2
  H]-serine (d3-Ser) CDN Isotopes.                                 T. brucei cell culture
       non-natural     phospholipids  standards   1,2-
diheptadecanoyl-sn-glycero-3-phosphate, GPA(17:0/17:0);                     Bloodstream form T. brucei brucei strain Lister 427, previ-
1,2-dipentadecanoyl-sn-glycerol-3-phosphoethanolamine                       ously genetically modified express T7 polymerase 
                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                              Ethanolamine metabolism Trypanosoma brucei 839

tetracycline repressor protein (Wirtz et al., 1999), referred       constructs purified using QIAprep Miniprep wild-type. cell line allows inducible expression    Plasmid Kit (Qiagen), linearized NotI, precipitated ectopic genes control T7 promoter           sodium acetate/ethanol dissolved sterile water tetracycline operator. Cells cultured 37Â°C 5            final concentration 2 mg ml-1. DNA elec-
CO2 HMI-9 medium supplemented 2.5 mg ml-1 G418           troporated T. brucei bloodstream form cells: 3 Â¥ 107 cells maintain neomycin drug pressure. TbECT conditional           suspended T-cell Nucleofector solution trans-
null mutant culturing media supplemented puromy-           fected using program X-001 AMAXA Biosystems
cin, phleomycin, hygromycyn tetracycline concen-         nucleofector. Transfected cells left recover HMI-9
trations section  Cells counted daily     medium overnight 6 h; 10-fold dilution cells average cell volume recorded CASY Cell Counter           applied stage. recovery, drug selection Analyser Model TT using lower upper cell dimen-          achieved presence final concentration sion limits 2.40 5.70 mm.                                    0.1 mg ml-1 puromycin cells containing PAC gene;
                                                                    2.5 mg ml-1 phleomycin cells transfected                                                                     pLew100 construct; 4 mg ml-1 hygromycyn cells
Stable isotope labelling bloodstream form T. brucei              containing HYG gene. deletion second
                                                                    TbECT allele expression ectopic TbECT ensured 2.5 Â¥ 107T. brucei bloodstream form cells density           addition 1 mg ml-1 tetracycline. concentration 0.5 Â¥ 106 cells ml-1 incubated overnight 37Â°C            maintained culturing TbECT conditional null mutant,
HMI-9 media supplemented 1 mM d3-Ser. Total lipids             arrest ECT gene expression achieved extracted method Bligh Dyer (1959),          washing cells times tetracycline-free HMI-9 prior samples analysed Micromass Quattro Ultima               culturing tetracycline-free HMI-9.
triple quadrupole mass spectrometer equipped nano-
electrospray source. [M-H] adducts unlabelled GPSer (d3)-
labelled GPSer, unlabelled GPEtn (d3)-labelled GPEtn            RNA isolation cDNA synthesis monitored neutral loss scanning m 96 99 parent ion scanning m 196 199 respectively.        Total RNA isolated bloodstream form T. brucei spectrum encompasses 50 repetitive scans.             using RNeasy mini kit (Qiagen). TbECT specific cDNA
                                                                    generated amplified using specific forward
                                                                    5â€²-GAGATATACATATGAAACGGTCGGTGTCGAAGG-3â€² Construction T. brucei ECT conditional gene knockout             reverse 5â€²-CCGGATCCTCACACCTCTCTGACATTTCTGTA
                                                                    C-3â€² primers using SuperScript III step RT-PCR kit construct T. brucei gene replacement cassettes, 5â€²       Platinum Taq (Invitrogen). negative control 3â€² UTRs adjacent TbECT ORF amplified           exclude DNA contamination RNA sample, reverse tran- pCR-Blunt-II-flECT construct using primers F1           scriptase omitted reaction replaced 5â€² - GGATCCGTTTAAACTTACGGACCGTCAAGCTTCAAAG                          GoTaq polymerase (Promega). Tubulin tyrosine-ligase
GGGTAAAACCCACAGATAC-3â€² (R1) 5â€²-UTR;                 (TbTTL) cDNA amplified using forward primers 5â€²-AAGCTTGACGGTCCGTAAGTTTAAACGGATCC                         reverse primers 5â€²-GGAATTCCATATGATGAGTGAGTTCC
ACTTTTATCCTTCGTGAGGAAT-3â€² (F2) R2 3â€²                    CGTTGGTGTC-3â€² 5â€²-CGCGGATCCGCGTCACGTGC
UTR. amplified products used knitting            TCCCGATAGGCAATTC-3â€² equal RNA input. PCR, utilized short linker region (underlined) containing    PCR products run 1  agarose gel. restriction sites BamHI, HindIII PmeI order anneal 5â€² 3â€² UTR.
   HindIII restriction site internal sequence       Southern Northern blotting
3â€²-UTR silenced site directed mutagenesis using forward primer 5â€²-CCATCAAAAAAGAAGGAGAAGCCTTGC                       Southern Northern blotting performed essentially
ATGGATAAGTAGAG-3â€², reverse primer 5â€²-CTCTACTT                   described (Martin Smith, 2006a), using TbECT
ATCCATGCAAGGCTTCTCCTTCTTTTTTGATGG-3â€²                        specific probes generated PCR using primers previ-
QuickChange Site Directed Mutagenesis Kit (Stratagene).             ously described amplification ECT ORF    stitched UTRs ligated pGEM-5Zf(+)             ligation pLew100.
(Promega) NotI sites antibiotic resistance
markers hygromycin phosphotransferase (HYG) puromy-
cin acetyltransferase (PAC) ligated BamHI          Subcellular localization studies HindIII restriction sites.                                      Immunofluorescence, subcellular fractionation differen-
   generate tetracycline inducible ectopic copy       tial centrifugation carried TbECT cKO cells
TbECT gene, ORF amplified PCR pCR-              grown presence tetracycline described Blunt-II-flECT construct using Pfu polymerase               (Martin Smith, 2006b).
forward reverse primers 5â€²-CCCAAGCTTGGGATG
AAACGGTCGGTGTCGAAGGT-3â€² 5â€²-CCTTAATTAAGG
CACCTCTCTGACATTTCTGTACA-3â€². PCR product                     Mitotracker staining cloned vector pLew100, contained phleomycin resistance cassette (Wirtz et al., 1999), using      Mid-log bloodstream form T. brucei parental SM cells HindIII PacI sites (underlined).                                TbECT cKO cells grown presence absence tet-

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 840 F. Gibellini, W. N. Hunter T. K. Smith äŠ?

racycline 36 42 h incubated 10 min 37Â°C                 twice 0.08 M sodium cacodylate pH 7.2 postfixed/ HMI-9 medium containing 50 nM Mitotracker Red CMXRos                     stained 1  osmium tetraoxide (aq) 1 h. Specimens
(Molecular Probes). Cells harvested, washed                    rinsed twice distilled water fixation/
HMI-9 medium incubated 30 min                        staining 3  uranyl acetate (aq) 16â€“18 h. Samples absence Mitotracker. Cells collected centrifugation              rinsed twice distilled water, dehydrated graded
(800 g, 10 min), washed PBS fixed 4 (w/v)                       ethanol series washed twice propylene oxide.
paraformaldehyde PBS. Cells counterstained                     Samples infiltrated 50  (v/v) mixture 4,6-diamidino-2-phenylindole (DAPI, 2 mg ml-1), washed                   Durcopan resin propylene oxide 24 h rotary
PBS, let adhere polylysine slides slides mounted.                mixer room temperature. infiltration 24 h
                                                                            100  Durcopan resin, samples polymerized 60Â°C
                                                                            24 h. Sections cut using Leica Ultracut UCT micro- vivo T. brucei metabolic labelling                                       tome, mounted pioloform coated copper grids, post
                                                                            stained 3  uranyl acetate (aq) Reynoldâ€™s lead metabolic labelling 2 Â¥ 107 mid-log cells centrifuged              citrate examined using JEOL-1200 EX transmission
(800 g, 10 min) washed  serine free Minimal Essential                electron microscope operating accelerating voltage Media (MEM), [3H]serine [3H]ethanolamine labelling;                 80 Kv.
methionine free MEM, [35S]methionine labelling; glucose
free MEM, [3H]mannose labelling MEM supplemented defatted BSA precoupled [3H]myristate                         Electrospray tandem mass spectrometry
[3H]myristate labelling. cells suspended                                                                             Total lipids 1 Â¥ 108 trypanosomes extracted appropriate media final concentration 1 Â¥ 107
                                                                            method Bligh Dyer (1959) natural lipid stan-
cells ml-1. Cells labelled 1 h 37Â°C 50 mCi ml-1
                                                                            dards added prior lipid extraction [1 nmol standard relevant radiolabelled species. aliquots containing
                                                                            sample, exception GPIno(12:0 13:0) 1 Â¥ 107 cells collected labelling
                                                                            0.2 nmol added sample]. Samples analysed
experiment centrifugation (800 g, 10 min) used                                                                             Micromass Quattro Ultima triple quadrupole mass
lipid protein analysis.
                                                                            spectrometer equipped nano-electrospray source,    Lipids extracted chloroform:methanol:water
                                                                            described previously (Guler et al., 2008). spectrum
(10:10:3) 1 h, supernatant removed pellet
                                                                            encompasses 50 repetitive scans.
extracted fresh 10:10:3 1 h. supernatants pooled dried stream nitrogen prior desalting
using butanol/water partitioning. Lipids separated                  TbECT recombinant protein expression purification
HPTLC using silica 60 HPTLC plates chloroform :
methanol : water (10:10:3 v/v) solvent. aqueous                  ECT ORF PCR amplified pCR-Blunt-II-
phases containing ethanolamine metabolites dried                   flECT construct Pfu polymerase using forward nitrogen stream separated HPTLC using                        primer 5â€²-GGAATTCCATATGATGAAACGGTCGGTGTCGA
silica 60 HPTLC plates solvent composed                      AG-3â€² containing NdeI restriction site (underlined) 100  ethanol : 0.5  sodium chloride : 25  ammonium                          reverse primer 5â€²-GGATCCCCTTGAAAATACAGGTTTTCG
hydroxide (10:10:1). Cold ethanolamine, ethanolamine-                       CCGCCGGTACCCACCTCTCTGACATTTCTGTACACATCT
phosphate CDP-ethanolamine standards run                        GGC-3â€², contains BamHI restriction site (underlined)
parallel detected ninhydrin. Radiolabelled species                 encodes product carrying TEV protease cleavage site detected fluorography -80Â°C, spraying                 (bold). amplicon purified (QIAquick PCR purification
En3hanceTM using Kodak Biomax MS film inten-                    kit, Qiagen), subcloned pCR-Blunt II TOPO (Invitrogen)
sifying screen. Proteins separated 4â€“12  SDS-                     sequenced. Using NdeI BamHI restriction sites
PAGE gel visualized Coomassie blue staining.                         putative TbECT ligated expression vector
Destained gel soaked En3hanceTM (NEN) 30 min,                    pET-20b (Novagen), generating construct pET20b-
washed water twice, soaked 10  glycerol dried.                  TbECT-TEVP-His6, incorporates C-terminal TEV dried gel exposed Kodak Biomax MS film                  cleavable hexa-histidine tag expressed.
7 days -80Â°C.                                                               pET20b-TbECT-TEVP-His6 construct transformed
                                                                            BL21(DE3) Codon plus RIL cells clones selected                                                                             LB-agar plates containing carbenicillin (100 mg ml-1) Electron microscopy                                                         chloramphenicol (25 mg ml-1). Starter cultures grown                                                                             37Â°C single colonies 10 ml LB medium containing scanning electron microscopy samples fixed                     carbenicillin (50 mg ml-1) chloramphenicol (12.5 mg ml-1),
directly HMI-9 media adding glutaraldehyde final                 5 h. starter culture used inoculate
concentration 2.5  (v/v) processed described                      1 l autoinduction media (Studier, 2005) cells (Urbaniak et al., 2006). Samples examined                  grown room temperature 24 h. Cells harvested using Philips XL 30 environmental scanning electron micro-                centrifugation (3500 g, 20 min, 4Â°C) suspended scope operating accelerating voltage 15 Kv.                        buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10 mM
   transmission electron microscopy cell pellets                   imidazole, 2 mM b-mercaptoethanol 5  glycerol). Cells
fixed 24 h Peterâ€™s fixative (1.25  glutatalde-               lysed presence Dnase using French
hyde, 1  paraformaldehyde 0.08 M sodium cacodylate                       press lysate cleared centrifugation (35 000 g,
pH 7.2 0.02  calcium chloride). Samples rinsed                    30 min, 4Â°C).

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                             Ethanolamine metabolism Trypanosoma brucei 841

   cleared lysate applied 5 ml HisTrapTM column        boiling 100Â°C 5 min. Substrates products (GE-Healthcare) preloaded Ni2+. Unbound proteins          separated HPTLC using silica 60 plates 100 
removed washing column 15 column volumes             ethanol : 0.5  sodium chloride : 25  ammonium hydroxide
buffer  TbECT eluted imidazole gradient         (10:10:1, v/v) solvent. Substrates products visu- buffer.                                                 alized spraying ninhydrin (0.2  water-saturated
   Fractions containing TbECT pooled tag           butan-1-ol). cleaved TEV protease (1 mg protease 10â€“20 mg protein substrate) containing uncleavable tag, dialysing buffer  cleaved TbECT        Cell-free assay GPI biosynthesis purified remaining tagged version                                                                     Membranes T. brucei wild-type TbECT conditional null
TbECT, tag tagged TEV protease second round nickel ion affinity chromatography,              mutants grown presence absence tetracycline described  Fractions containing cleaved TbECT            30, 36 42 h isolated prepared described
pooled, purity sample checked SDS-PAGE,           previously  addition tunicamycin prior lysis) aliquots snap frozen liquid nitrogen stored      (Smith et al., 1997), snap frozen liquid nitrogen stored
-80Â°C.                                                              -80Â°C required. cell-free assay                                                                     carried visualized described (Smith et al.,
   order assess molecular weight oligomeric
                                                                    1997) using 1 Â¥ 107 cell equivalents assay, GDP-
state solution TbECT, protein purified                                                                     [3H]Mannose (0.3 mCi 107 cell equivalents) glycerol, interfere analyses,                                                                     1 mM PMSF.
omitted purification buffers. Exact molecular weight assessed MALDI time flight mass spectrometry.
Sedimentation velocity experiments performed (wave-
length 280 nm, rotor AN50-TI 45 000 r.p.m. 20Â°C),
                                                                    Acknowledgements
using Beckman Coulter XL-1 analytical ultracentrifuge.        authors like thank Martin Kierans John
samples run 25 mM HEPES pH 7.5, 50 mM NaCl,                 James (CHIPs facility, University Dundee) assistance
2 mM DTT, 2 mM MgCl2 concentrations 0.25, 0.5             electron microscopy. authors like 0.75 mg ml-1. Samples centrifuged simultaneously           thank Mark Agacan (Dundee) running AUC. work
A280 measurements taken minute intervals 16 h.          supported Wellcome Trust Senior Research resultant data analysed using programs                 Fellowship 067441(T.K.S.), Wellcome Trust grants 082596
SEDFIT SEDNTERP (Schuck, 2000; Lebowitz et al.,                 083481 (WNH) Wellcome Trust PhD studentship
2002).                                                              (F.G.).

Assay TbECT activity
                                                                    Note added proof
Ethanolamine-phosphate cytidylyltransferase activity                                                                     nucleotide sequence reported paper measured malachite green colorimetric assay 96                                                                     submitted GenBankTM/EBI Data Bank accession
plate format using SpectraMAX 340PC plate reader
                                                                    number FM992871.
(Molecular Devices). assay contained 25 mM Bis-tris
propane pH 7.5, 5 mM MgCl2, 1.425 mg ml-1 recombinant
TbECT, 0.1 unit inorganic pyrophosphatase (Sigma)            References
varying concentrations CTP Etn-P, total volume 50 ml. reaction carried 5 min room tem-          Ancelin, M.L., Vial, J.H. (1986) Quaternary ammonium
perature stopped addition 100 ml malachite           compounds efficiently inhibit Plasmodium falciparum
green reagent (Biomol Green), absorbance recorded             growth vitro impairment choline transport. Anti- 620 nm. Controls conducted make sure enzyme                microb Agents Chemother 29: 814â€“820.
activity product formation displayed linear relationship      Baer, E., Stanacev, N  (1964) Phosphonolipids. J Biol time span assay. enzyme assays             Chem 239: 3209â€“3214.
ducted triplicate. Enzyme Kinetics, SigmaPlot           Bakovic, M., Fullerton, M.D., Michel, V. (2007) Metabolic
(SPSS), used analyse fit kinetic data. Sub-            molecular aspects ethanolamine phospholipid bio-
strate recognition investigated substituting            synthesis: role CTP:phosphoethanolamine cytidylyl-
Etn-P CTP substrate analogues alternative nucle-           transferase (Pcyt2). Biochem Cell Biol 85: 283â€“300.
otide phosphates.                                                   Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G.,
   pH optimum reaction assessed measur-             Renauld, H., Bartholomeu, D.C., et al. (2005) genome
ing TbECT activity various pHs: Bis-Tris methane (pH 6.5,          African trypanosome Trypanosoma brucei. Science
7.0), Bis-Tris propane (pH 7.5, 8.0, 8.5) Glycine (pH 9.0).        309: 416â€“422.
   production CDP-ethanolamine ethanolamine-          Bladergroen, B , Houweling, M., Geelen, M.J.H., phosphate cytidylyltransferase assay assessed using             van Golde, L.M.G. (1999) Cloning expression modified method Tijburg et al. (1992). Briefly, 2 mg puri-      CTP:phosphoethanolamine cytidylyltransferase cDNA fied protein incubated reaction mixture (total             rat liver. Biochem J 143: 107â€“114.
volume 50 ml) 100 mM Tris pH 8, 10 mM MgCl2, 5 mM                Bleijerveld, O.B., Klein, W., Vaandrager, B., Helms, J.B.,
CTP, 4 mM Etn-P 37Â°C 20 min quenched                Houweling, M. (2004) Control CDPethanolamine

Â© 2009 Authors
Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
 842 F. Gibellini, W. N. Hunter T. K. Smith äŠ?

   pathway mammalian cells: effect CTP:phosphoetha-                   Menon, K., Eppingerl, M., Mayor, S., Schwarz, R.
   nolamine cytidylyltransferase overexpression                       (1993) Phosphatidylethanolamine donor    intracellular diacylglycerol. Biochem J 379: 711â€“                phosphoethanolamine group trypanosome glycosyl-
   719.                                                                       phosphatidylinositol. EMBO J 12: 1907â€“1914.
Bligh, E.G., Dyer, W.J. (1959) rapid method total                  Mizoi, J., Nakamura, M., Nishida,  (2006) Defects    lipid extraction purification. J Biochem Physiol 37:               CTP:phosphorylethanolamine cytidylyltransferase affect
   911â€“917.                                                                   embryonic postembryonic development Arabidopsis.
Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K.,                  Plant Cell 18: 3370â€“3385.
   Puri, S.K., Bandyopadhyay, U. (2007) Inhibition                   Nagamune, K., Nozaki, T., Maeda, Y., Ohishi, K., Fukuma,
   Plasmodium falciparum choline kinase hexadecyl-                         T., Hara, T., et al. (2000) Critical roles glycosylphos-
   trimethylammonium bromide: possible antimalarial                         phatidylinositol Trypanosoma brucei. Proc Natl Acad Sci
   mechanism. Antimicrob Agents Chemother 51: 696â€“706.                        USA 97: 10336â€“10341.
Dowhan, W. (1997) Molecular basis membrane phospho-                     Nakashima, , Hosaka, K., Nikawa, J. (1997) Cloning    lipid diversity: lipids? Annu Rev                    human cDNA CTP-phosphoethanolamine cytidylyl-
   Biochem 66: 199â€“232.                                                       transferase complementation vivo yeast mutant.
Ferguson, M J., Allen, K., Snary, D. (1982)                       J Biol Chem 272: 9567â€“9572.
   detection phosphonolipids protozoan Trypano-                   Ohtsuka, J., Nagata, K., Lee, W.C., Ono, Y., Fukuda, R.,
   soma cruzi. Biochem J 207: 171â€“174.                                        Ohtab, , Tanokura, M. (2006) Crystallization Guler, J.L., Kriegova, E., Smith, T.K., Lukes, J., Englund,               preliminary X-ray analysis CTP:phosphoethanolamine
   P.T. (2008) Mitochondrial fatty acid synthesis required                 cytidylyltransferase (ECT) Saccharomyces cerevisiae.
   normal mitochondrial morphology function                        Acta Cryst F62: 1003â€“1005.
   Trypanosoma brucei. Mol Microbiol 67: 1125â€“1142.                         Pattridge, K , Weber, C.H., Friesen, J , Sanker, S., Kent,
Guther, M.L.S., Masterson, W.J., Ferguson, M J.                         C., Ludwig, M.L. (2003) Glycerol-3-phosphate
   (1994) effects phenylmethylsulfonyl fluoride                     cytidylyltransferase. J Biol Chem 278: 51863â€“51871.
   inositol-acylation fatty acid remodeling African                  Rifkin, M.R., Strobos, C M., Fairlamb, H. (1995)
   trypanosomes. J Biol Chem 269: 18694â€“18701.                                Specificity ethanolamine transport van Hellemond, J.J., Tielens, G.M. (2006) Adaptations                   metabolism Trypanosoma brucei. J Biol Chem 270:
   lipid metabolism protozoan parasite Trypano-                 16160â€“16166.
   soma brucei. FEBS Lett 580: 5552â€“5558.                                   Roper, J.R., Guther, M.L.S., Milne, K.G., Ferguson,
HernÃ¡ndez-Alcoceba, R., Saniger, L., Campos, J., NÃºÃ±ez.                       M J. (2002) Galactose metabolism essential    M.C., Khaless, F., Gallo, M , et al. (1997) Choline kinase               African sleeping sickness parasite Trypanosoma brucei.
   inhibitors novel approach antiproliferative drug                  Proc Natl Acad Sci USA 99: 5884â€“5889.
   design. Oncogene 15: 2289â€“2301.                                          Sarkar, M., Hamilton, C.J., Fairlamb, H. (2003) Prop-
Hofer, , Ekanem, J.T., Thelander, L. (1998) Allosteric                  erties phosphoenolpyruvate mutase, enzyme    regulation Trypanosoma brucei ribonucleotide reductase                  aminoethylphosphonate biosynthetic pathway Trypa-
   studied vitro vivo. J Biol Chem 273: 34098â€“                      nosoma cruzi. J Biol Chem 278: 22703â€“22708.
   34104.                                                                   Schuck, P. (2000) Size distribution analysis macro-
Imhof, , Canivenc-Gansel, E., Meyer, U., Conzelmann,                    molecules sedimentation velocity ultracentrifugation
    (2000) Phosphatidylethanolamine donor                         Lamm equation modeling. Biophys J 78: 1606â€“1619.
   phosphorylethanolamine linked 1,4-linked                    Signorell, , Jelk, J., Rauch, M., BÃ¼tikofer, P. (2008a)
   mannose yeast GPI structure. Glycobiology 10: 1271â€“                     Phosphatidylethanolamine precursor ethano-
   1275.                                                                      lamine phosphoglycerol moiety bound eukaryotic elon-
Jez, J.M. (2007) Phosphatidylcholine biosynthesis                        gation factor 1A. J Biol Chem 283: 20320â€“20329.
   potential target inhibition metabolism parasitic               Signorell, , Rauch, M., Jelk, J., Ferguson, M J.,    nematodes. Current Enzyme Inhibition 3: 133â€“142.                           BÃ¼tikofer, P. (2008b) Phosphatidylethanolamine Trypa-
Lazarowski, E.R., Boucher, R.C. (2001) UTP extra-                   nosoma brucei organized separate pools    cellular signalling molecule. News Physiol Sci 16: 1â€“5.                    synthesized exclusively Kennedy pathway. J Biol
Lebowitz, J., Lewis, M.S., Schuck, P. (2002) Modern                       Chem 283: 23636â€“23644.
   analytical ultracentrifugation protein science: tutorial            Smith, T.K., Cottaz. S., Brimacombe, J.S., Ferguson,
   review. Protein Sci 11: 2067â€“2079.                                         M J. (1996) Substrate specificity Dol-P-
Martin, K.L., Smith, T.K. (2006a) Phosphatidylinositol                    Man:GlcN-PI a1â€“4 mannosyltransferase glyco-
   synthesis essential bloodstream form Trypanosoma                     sylphosphatidylinositol biosynthetic pathway African
   brucei. Biochem J 396: 287â€“295.                                            Trypanosomes. J Biol Chem 271: 6476â€“6482.
Martin, K.L., Smith, T.K. (2006b) glycosylphosphati-                Smith, T.K., Sharma, D.K., Crossman, , Dix, , Brima-
   dylinositol (GPI) biosynthetic pathway bloodstream form                 combe, J.S., Ferguson, M J. (1997) Parasite    Trypanosoma brucei dependent novo synthe-                     mammalian GPI biosynthetic pathways distin-
   sis inositol. Mol Microbiol 61: 89â€“105.                                 guished using synthetic substrate analogues. EMBO J 16:
Menon, K., Stevens, V.L. (1992) Phosphatidylethano-                     6667â€“6675.
   lamine donor ethanolamine residue linking                Steenbergen, R., Nanowski, T.S., Beigneux, , Kulinski, ,
   glycosylphosphatidylinositol anchor protein. J Biol Chem                Young, S.G., Vance, J.E. (2005) Disruption    267: 15277â€“15280.                                                          phosphatidylserine decarboxylase gene mice causes

                                                                                                                        Â© 2009 Authors
                                                   Journal compilation Â© 2009 Blackwell Publishing  Molecular Microbiology, 73, 826â€“843
                                                                                              Ethanolamine metabolism Trypanosoma brucei 843

   embryonic lethality mitochondrial defects. J Biol Chem         ethanolamine cytidylyltransferase purified rat liver.
   280: 40032â€“40040.                                